This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
Does Lemon's Bitcoin Credit Card Hint at V's Next Crypto Growth Lane?
by Zacks Equity Research
A Bitcoin-backed credit card on Visa's network lets users spend pesos while holding crypto, highlighting a new path for crypto-linked credit growth.
MANegative Net Change VNegative Net Change AXPNegative Net Change
business-services cryptocurrency fin-tech payments
NU Expands Heavily in Brazil: Can It Replicate the Same in Mexico?
by Arghyadeep Bose
Nu Holdings builds a 60% adult reach in Brazil and now targets Mexico, where adoption hit 14% and ARPAC reached $12.5, testing if the S-curve can repeat.
NUPositive Net Change BMOPositive Net Change BNPQYPositive Net Change
fin-tech finance
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific
by Zacks Equity Research
Visa, AMD and Thermo Fisher Scientific headline Zacks' top analyst reports, spotlighting digital payments strength, AI-driven chip demand and life-sciences innovation.
AMDPositive Net Change VNegative Net Change TMONegative Net Change
fin-tech
1 Fintech Disruptor + 2 Mag 7 Stocks to Buy as Momentum Surges
by Tirthankar Chakraborty
Nu Holdings stands out as a momentum leader as Driehaus' buy-high strategy highlights strong trends and earnings surprises driving further upside.
AMZNPositive Net Change MSFTPositive Net Change NUPositive Net Change
fin-tech tech-stocks
Why Mastercard's API-First Strategy Is Becoming a Growth Multiplier
by Rajshree Sipani
MA's API-first push is turning it into a payments infrastructure, embedding tokenization, fraud and open banking to drive stickier, higher-margin growth.
MANegative Net Change VNegative Net Change AXPNegative Net Change
fin-tech payments
Reasons Why You Should Retain WEX Stock in Your Portfolio
by Zacks Equity Research
Shares of WEX have risen 5.2% in a month as earnings growth expectations build, driven by Mobility, Benefits and Corporate Payments, plus AI and EV initiatives.
CRAINegative Net Change IIIPositive Net Change WEXNegative Net Change
business-services fin-tech
Is SoFi's Scalable Profitability the Key to Its Stronger 2025 Outlook?
by Zacks Equity Research
SOFI's scalable profitability drives higher 2025 guidance, with stronger member growth, revenue outlook and a sharp boost to tangible book value.
LCNegative Net Change UPSTNegative Net Change SOFINegative Net Change
fin-tech finance
MercadoLibre vs Shopify: Which Digital Commerce Stock Holds an Edge?
by Kashvi Chandgothia
SHOP's capital-light model, global diversification and margin gains put it ahead of MELI facing Latin America volatility.
MELIPositive Net Change SHOPPositive Net Change
artificial-intelligence e-commerce fin-tech retail
After Golden Cross, Adeia (ADEA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADEANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BNP Paribas SA (BNPQY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BNPQYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines